The smart shirt is mainly used by athletes to monitor their lung function, but a recent Dutch study wanted to test it for validity and reproducibility for potential use for patients [1]. Symptoms of disease worsening normally start in exercise situations. However, it is difficult to get realistic values for these situations as lung function tests are mostly performed in a clinical setting, which does not adequately reflect the conditions in which a person is performing everyday tasks like climbing stairs, sitting, or vacuuming. This was the incentive for Denise Mannée (Radboud University Medical Centre, the Netherlands) and her colleagues to compare the tidal volume (TV) measured by the Hexoskin®shirt to TV values from mobile spirometry with an Oxycon Mobile® (OM) in 15 healthy subjects with a mean age of 34.1 years. TV values determined by the shirt were tested against the QCD-calibrated respiratory inductance plethysmography with a breathing mask and backpack. Every test person had to perform the tasks twice to account for reproducibility.
The registered TV ranged from 0.64L ± 0.13L while sitting in a bent position to 1.63L ± 0.49L while climbing stairs. Mobile spirometry and smart shirt values for standing and sitting in a bent position differed 0.2%, stair climbing differed 2.0%, and the biggest disparity appeared while vacuuming (3.1%). A 1% difference equalled about 12 mL of TV. Of note, a new calibration was needed for the second measurement, but in general the researchers valued the smart shirt for its accurate measurement of TV. Ms Mannée concluded, “Ultimately, we want to improve patients’ quality of life. If we can accurately monitor patients’ symptoms while they go about their normal activities, we might be able to spot problems and treat them sooner, and this, in turn, could mean less time in hospital.”
- Mannée D, et al. PA2228, ERS 2019, 29.9.-2.10 Madrid, Spain.
Posted on
Previous Article
« Reduction of FVC decline in systemic sclerosis-associated ILD Next Article
Vaccines show multiple positive effects with respect to respiratory health »
« Reduction of FVC decline in systemic sclerosis-associated ILD Next Article
Vaccines show multiple positive effects with respect to respiratory health »
Table of Contents: ERS 2019
Featured articles
Letter from the Editor
Interview with ERS president Prof. Tobias Welte
Holistic View on Asthma
Holistic view on asthma
COPD Management
COPD patients derive clinical benefit from β-blockers
COPD patients harbouring Pseudomonas Aeruginosa face high risk of hospitalisation
One blood eosinophil count is sufficient to guide ICS therapy
Female COPD patients frequently suffer from anxiety and depression
Dual bronchodilation improves ventilation dynamics in COPD patients
Vaping
Vaping impairs innate immune response of the airway
Alternative nicotine delivery products: no help in smoking cessation
Air Pollution
Pregnant women and their offspring: a high-risk group for air pollution
Taxi drivers exposed to highest levels of black carbon pollution
Infectious Respiratory Disease: the Role of Vaccines
Vaccines show multiple positive effects with respect to respiratory health
Pneumococcal vaccines: an effective way to reduce COPD hospitalisations
Interstitial Lung Disease
Antifibrotic therapy slows disease progression in ILD
Reduction of FVC decline in systemic sclerosis-associated ILD
Registry confirms nintedanib efficacy under real-life conditions
Best of the Posters
Fever during immunotherapy for NSCLC associated with shorter PFS
Smart shirt as a device to measure tidal volumes in real-life setting
Exercise with virtual reality beneficial for COPD patients
NSCLC: A new way to evaluate hilar and mediastinal lymph nodes
COPD patients do not benefit from azithromycin therapy longer than a year
Novel Developments in Infectious Disease
Long-term azithromycin decreases exacerbations in primary ciliary dyskinesia
Predicting community-acquired pneumonia outcomes by microRNA testing
Pulmonary Vascular Disease
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
Related Articles
January 14, 2022
Remote healthcare programme improves hypertension and lipid control
September 10, 2020
Intensive hypertension treatment lowers risk of orthostatic hypotension
June 6, 2019
Treatment patterns PAH have changed recently
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com